新型机器学习技术进一步明确无关供者选择以优化移植结局
本研究采用非参数失效时间贝叶斯加性回归树(NFT BART)机器学习方法,在10016例2016至2019年间接受首次HLA-A、B、C、DRB1相合无关供者(MUD)造血细胞移植(HCT)并报告至国际血液与骨髓移植研究中心的患者数据上训练模型,并在1802例独立队列中验证。研究以3年预测结局差异>1%定义临床有意义影响,发现供者年龄是与总生存(OS)唯一显著相关的供者因素,供者年龄≤32岁及使用男性供者可改善无事件生存(EFS)。作者据此推荐选择18至30岁范围内最早可用的供者以优化OS。
要点
- 供者年龄是与OS唯一显著相关的供者因素,≥31岁供者较18岁供者OS更低。
- 供者年龄≤32岁及使用男性供者(无论受者性别)均可改善EFS。
- 作者推荐选择18至30岁范围内最早可用供者,若有多名可选男性供者以优化EFS。
核心结论
- 作者推荐选择18至30岁年龄范围内最早可用的供者进行HCT以优化OS。
- 若18至30岁范围内有多名供者可用,可选择男性供者以优化EFS。
研究设计与样本
- 研究采用新型机器学习方法非参数失效时间贝叶斯加性回归树(NFT BART)建模。
- 模型在10016例2016至2019年间接受首次HLA-A、B、C、DRB1相合无关供者(MUD)HCT并报告至国际血液与骨髓移植研究中心的患者数据上训练。
- 模型在1802例独立队列患者中验证。
- NFT BART模型基于受者、疾病和移植变量进行调整。
主要发现
- 供者巨细胞病毒、产次、HLA-DQB1和HLA-DPB1 T细胞表位匹配落在无差异区域内(3年预测结局差异<1%)。
- 与18岁供者相比,年龄≥31岁供者与更低的OS相关。
- 供者年龄≤32岁及使用男性供者(无论受者性别)均改善EFS。
关键数值与推荐
- 临床有意义影响定义为3年预测结局差异>1%。
- 影响<1%(位于无差异区域内)的特征不被认为具有临床相关性。
临床怎么用
- 作者推荐选择18至30岁年龄范围内最早可用的供者以优化OS。
- 若18至30岁范围内有多名供者可用,作者认为可选择男性供者以优化EFS。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We investigated the impact of donor characteristics on outcomes in allogeneic hematopoietic cell transplantation (HCT) recipients using a novel machine learning approach, the Nonparametric Failure Time Bayesian Additive Regression Trees (NFT BART). NFT BART models were trained on data from 10 016 patients who underwent a first HLA-A, B, C, and DRB1 matched unrelated donor (MUD) HCT between 2016 and 2019, reported to the Center for International Blood and Marrow Transplant Research, then validated on an independent cohort of 1802 patients. The NFT BART models were adjusted based on recipient, disease, and transplant variables. We defined a clinically meaningful impact on overall survival (OS) or event-free survival (EFS; survival without relapse, graft failure, or moderate to severe chronic graft-versus-host disease) as >1% difference in predicted outcome at 3 years. Characteristics with <1% impact (within a zone of indifference) were not considered to be clinically relevant. Donor cytomegalovirus, parity, HLA-DQB1, and HLA-DPB1 T-cell epitope matching fell within the zone of indifference. The only significant donor factor that associated with OS was age, in which, compared with 18-year-old donors, donors aged ≥31 years old were associated with lower OS. Both donor age (≤32 years) and use of a male donor, regardless of recipient sex, improved EFS. We, therefore, recommend selecting the earliest available donor within the 18 to 30 years age range for HCT to optimize OS. If several donors in the 18 to 30 years age range are available, a male donor may be chosen to optimize EFS.
引用
- Spellman SR, Sparapani R, Maiers M, et al. Novel machine learning technique further clarifies unrelated donor selection to optimize transplantation outcomes. Blood Adv. 2024. PMID: 39368807. doi:10.1182/bloodadvances.2024013756
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。